Physician profile
Kirk Smick
NPI 1023002540
$25,084.63
in general payments reported to CMS, 2019-2025
7 companies · $29.06 in 2025
The $29.06 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $6,326 · 2021: $1,592 · 2022: $1,900 · 2023: $3,486 · 2024: $1,625 · 2025: $29.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,700 · Food and Beverage: $440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,700.00 |
| Food and Beverage | $439.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $18,044.75 | 2019-2021 | |
| Abbvie INC. | $1,929.06 | 2022-2025 | |
| Topcon Healthcare, INC. | $1,500.00 | 2024 | |
| Tearlab Corp | $1,355.56 | 2023 | Tearlab Osmolarity System |
| Thea Pharma INC. | $1,250.00 | 2023 | Iyuzeh |
| Bausch & Lomb Americas INC. | $880.11 | 2023 | Miebo, Doctors Allergy Formula |
| Tarsus Pharmaceuticals, INC. | $125.15 | 2024 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Smick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.